Sandoz Group AG (SDZNY)
OTCMKTS
· Delayed Price · Currency is USD
44.91
-0.01 (-0.02%)
May 13, 2025, 3:55 PM EDT
Sandoz Group AG Employees
Sandoz Group AG had 22,049 employees as of December 31, 2024. The number of employees decreased by 584 or -2.58% compared to the previous year.
Employees
22,049
Change (1Y)
-584
Growth (1Y)
-2.58%
Revenue / Employee
$470,951
Profits / Employee
n/a
Market Cap
19.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22,049 | -584 | -2.58% |
| Dec 31, 2023 | 22,633 | 895 | 4.12% |
| Dec 31, 2022 | 21,738 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| Elite Pharmaceuticals | 64 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Sandoz Group AG News
- 11 days ago - Sandoz Group AG (SDZNY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed - GlobeNewsWire
- 14 days ago - Sandoz inks agreement with Shanghai Henlius for Bristol Yervoy biosimilar - Seeking Alpha
- 14 days ago - Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications - GlobeNewsWire
- 15 days ago - Sandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient access - Reuters
- 4 weeks ago - Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG - GlobeNewsWire
- 4 weeks ago - Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug - Benzinga
- 4 weeks ago - [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US - GlobeNewsWire